Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Kämpe O[au]:

Autoimmune Polyendocrine Syndromes. Husebye ES et al. N Engl J Med. (2018)

Autoimmune Polyendocrine Syndromes. Husebye ES et al. N Engl J Med. (2018)

Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency. Husebye ES et al. J Intern Med. (2014)

Search results

Items: 1 to 50 of 161

1.

Comment on 'AIRE-deficient patients harbor unique high-affinity disease-ameliorating autoantibodies'.

Landegren N, Rosen LB, Freyhult E, Eriksson D, Fall T, Smith G, Ferre EMN, Brodin P, Sharon D, Snyder M, Lionakis M, Anderson M, Kämpe O.

Elife. 2019 Jun 27;8. pii: e43578. doi: 10.7554/eLife.43578.

2.

The autoimmune targets in IPEX are dominated by gut epithelial proteins.

Eriksson D, Bacchetta R, Gunnarsson HI, Chan A, Barzaghi F, Ehl S, Hallgren Å, van Gool F, Sardh F, Lundqvist C, Laakso SM, Rönnblom A, Ekwall O, Mäkitie O, Bensing S, Husebye ES, Anderson M, Kämpe O, Landegren N.

J Allergy Clin Immunol. 2019 Jul;144(1):327-330.e8. doi: 10.1016/j.jaci.2019.02.031. Epub 2019 Apr 23. No abstract available.

3.

Sex-Specific Risk of Cardiovascular Disease in Autoimmune Addison Disease-A Population-Based Cohort Study.

Skov J, Sundström A, Ludvigsson JF, Kämpe O, Bensing S.

J Clin Endocrinol Metab. 2019 Jun 1;104(6):2031-2040. doi: 10.1210/jc.2018-02298.

4.

Is there a need for an emergency card in hypoparathyroidism?

Astor MC, Zhu W, Björnsdottir S, Bollerslev J, Kämpe O, Husebye ES.

J Intern Med. 2019 Apr;285(4):429-435. doi: 10.1111/joim.12865. Epub 2018 Dec 12.

PMID:
30485554
5.

Autoimmune Polyendocrine Syndromes.

Husebye ES, Anderson MS, Kämpe O.

N Engl J Med. 2018 Jun 28;378(26):2543-2544. doi: 10.1056/NEJMc1805308. No abstract available.

PMID:
29949487
6.

Common genetic variation in the autoimmune regulator (AIRE) locus is associated with autoimmune Addison's disease in Sweden.

Eriksson D, Bianchi M, Landegren N, Dalin F, Skov J, Hultin-Rosenberg L, Mathioudaki A, Nordin J, Hallgren Å, Andersson G, Tandre K, Rantapää Dahlqvist S, Söderkvist P, Rönnblom L, Hulting AL, Wahlberg J, Dahlqvist P, Ekwall O, Meadows JRS, Lindblad-Toh K, Bensing S, Rosengren Pielberg G, Kämpe O.

Sci Rep. 2018 May 30;8(1):8395. doi: 10.1038/s41598-018-26842-2.

7.

Hypomorphic Rag1 mutations alter the preimmune repertoire at early stages of lymphoid development.

Ott de Bruin LM, Bosticardo M, Barbieri A, Lin SG, Rowe JH, Poliani PL, Ching K, Eriksson D, Landegren N, Kämpe O, Manis JP, Notarangelo LD.

Blood. 2018 Jul 19;132(3):281-292. doi: 10.1182/blood-2017-12-820985. Epub 2018 May 9.

8.

Autoimmune Polyendocrine Syndromes.

Husebye ES, Anderson MS, Kämpe O.

N Engl J Med. 2018 Mar 22;378(12):1132-1141. doi: 10.1056/NEJMra1713301. Review. No abstract available.

9.

ILF2 and ILF3 are autoantigens in canine systemic autoimmune disease.

Bremer HD, Landegren N, Sjöberg R, Hallgren Å, Renneker S, Lattwein E, Leonard D, Eloranta ML, Rönnblom L, Nordmark G, Nilsson P, Andersson G, Lilliehöök I, Lindblad-Toh K, Kämpe O, Hansson-Hamlin H.

Sci Rep. 2018 Mar 19;8(1):4852. doi: 10.1038/s41598-018-23034-w.

10.

Clues for early detection of autoimmune Addison's disease - myths and realities.

Saevik ÅB, Åkerman AK, Grønning K, Nermoen I, Valland SF, Finnes TE, Isaksson M, Dahlqvist P, Bergthorsdottir R, Ekwall O, Skov J, Nedrebø BG, Hulting AL, Wahlberg J, Svartberg J, Höybye C, Bleskestad IH, Jørgensen AP, Kämpe O, Øksnes M, Bensing S, Husebye ES.

J Intern Med. 2018 Feb;283(2):190-199. doi: 10.1111/joim.12699. Epub 2017 Nov 3.

PMID:
29098731
11.

Cytokine Autoantibody Screening in the Swedish Addison Registry Identifies Patients With Undiagnosed APS1.

Eriksson D, Dalin F, Eriksson GN, Landegren N, Bianchi M, Hallgren Å, Dahlqvist P, Wahlberg J, Ekwall O, Winqvist O, Catrina SB, Rönnelid J; Swedish Addison Registry Study Group, Hulting AL, Lindblad-Toh K, Alimohammadi M, Husebye ES, Knappskog PM, Rosengren Pielberg G, Bensing S, Kämpe O.

J Clin Endocrinol Metab. 2018 Jan 1;103(1):179-186. doi: 10.1210/jc.2017-01957.

PMID:
29069385
12.

Heritability of Addison's disease and prevalence of associated autoimmunity in a cohort of 112,100 Swedish twins.

Skov J, Höijer J, Magnusson PKE, Ludvigsson JF, Kämpe O, Bensing S.

Endocrine. 2017 Dec;58(3):521-527. doi: 10.1007/s12020-017-1441-z. Epub 2017 Oct 16.

13.

Expanding the Phenotypic and Genotypic Landscape of Autoimmune Polyendocrine Syndrome Type 1.

Orlova EM, Sozaeva LS, Kareva MA, Oftedal BE, Wolff ASB, Breivik L, Zakharova EY, Ivanova ON, Kämpe O, Dedov II, Knappskog PM, Peterkova VA, Husebye ES.

J Clin Endocrinol Metab. 2017 Sep 1;102(9):3546-3556. doi: 10.1210/jc.2017-00139.

PMID:
28911151
14.

Identification of endothelin-converting enzyme-2 as an autoantigen in autoimmune polyendocrine syndrome type 1.

Smith-Anttila CJA, Bensing S, Alimohammadi M, Dalin F, Oscarson M, Zhang MD, Perheentupa J, Husebye ES, Gustafsson J, Björklund P, Fransson A, Nordmark G, Rönnblom L, Meloni A, Scott RJ, Hökfelt T, Crock PA, Kämpe O.

Autoimmunity. 2017 Jun;50(4):223-231. doi: 10.1080/08916934.2017.1332183. Epub 2017 May 30.

PMID:
28557628
15.

Autoimmune polyendocrine syndrome type 1 in an Indian cohort: a longitudinal study.

Zaidi G, Bhatia V, Sahoo SK, Sarangi AN, Bharti N, Zhang L, Yu L, Eriksson D, Bensing S, Kämpe O, Bharani N, Yachha SK, Bhansali A, Sachan A, Jain V, Shah N, Aggarwal R, Aggarwal A, Srinivasan M, Agarwal S, Bhatia E.

Endocr Connect. 2017 Jul;6(5):289-296. doi: 10.1530/EC-17-0022. Epub 2017 Apr 26.

16.

Vedolizumab as a successful treatment of CTLA-4-associated autoimmune enterocolitis.

Navarini AA, Hruz P, Berger CT, Hou TZ, Schwab C, Gabrysch A, Higgins R, Frede N, Padberg Sgier BC, Kämpe O, Burgener AV, Marquardsen F, Baldin F, Bigler M, Kistner A, Jauch A, Bignucolo O, Meyer B, Meienberg F, Mehling M, Jeker LT, Heijnen I, Daikeler TD, Gebbers JO, Grimbacher B, Sansom DM, Jeker R, Hess C, Recher M.

J Allergy Clin Immunol. 2017 Mar;139(3):1043-1046.e5. doi: 10.1016/j.jaci.2016.08.042. Epub 2016 Nov 28. No abstract available.

PMID:
27908448
17.

Clinical and Immunological Characteristics of Autoimmune Addison Disease: A Nationwide Swedish Multicenter Study.

Dalin F, Nordling Eriksson G, Dahlqvist P, Hallgren Å, Wahlberg J, Ekwall O, Söderberg S, Rönnelid J, Olcén P, Winqvist O, Catrina SB, Kriström B, Laudius M, Isaksson M, Halldin Stenlid M, Gustafsson J, Gebre-Medhin G, Björnsdottir S, Janson A, Åkerman AK, Åman J, Duchen K, Bergthorsdottir R, Johannsson G, Lindskog E, Landin-Olsson M, Elfving M, Waldenström E, Hulting AL, Kämpe O, Bensing S.

J Clin Endocrinol Metab. 2017 Feb 1;102(2):379-389. doi: 10.1210/jc.2016-2522.

PMID:
27870550
18.

Extended exome sequencing identifies BACH2 as a novel major risk locus for Addison's disease.

Eriksson D, Bianchi M, Landegren N, Nordin J, Dalin F, Mathioudaki A, Eriksson GN, Hultin-Rosenberg L, Dahlqvist J, Zetterqvist H, Karlsson Å, Hallgren Å, Farias FH, Murén E, Ahlgren KM, Lobell A, Andersson G, Tandre K, Dahlqvist SR, Söderkvist P, Rönnblom L, Hulting AL, Wahlberg J, Ekwall O, Dahlqvist P, Meadows JR, Bensing S, Lindblad-Toh K, Kämpe O, Pielberg GR.

J Intern Med. 2016 Dec;280(6):595-608. doi: 10.1111/joim.12569. Epub 2016 Nov 2.

19.

Prevalence of Celiac Disease in Patients with Autoimmune Thyroid Disease: A Meta-Analysis.

Roy A, Laszkowska M, Sundström J, Lebwohl B, Green PH, Kämpe O, Ludvigsson JF.

Thyroid. 2016 Jul;26(7):880-90. doi: 10.1089/thy.2016.0108. Review.

PMID:
27256300
20.

A Longitudinal Follow-up of Autoimmune Polyendocrine Syndrome Type 1.

Bruserud Ø, Oftedal BE, Landegren N, Erichsen MM, Bratland E, Lima K, Jørgensen AP, Myhre AG, Svartberg J, Fougner KJ, Bakke Å, Nedrebø BG, Mella B, Breivik L, Viken MK, Knappskog PM, Marthinussen MC, Løvås K, Kämpe O, Wolff AB, Husebye ES.

J Clin Endocrinol Metab. 2016 Aug;101(8):2975-83. doi: 10.1210/jc.2016-1821. Epub 2016 Jun 2.

21.

Identification of autoimmune polyendocrine syndrome type 1 in patients with isolated hypoparathyroidism.

Sahoo SK, Zaidi G, Srivastava R, Sarangi AN, Bharti N, Eriksson D, Bensing S, Kämpe O, Aggarwal A, Aggarwal R, Bhatia E.

Clin Endocrinol (Oxf). 2016 Oct;85(4):544-50. doi: 10.1111/cen.13111. Epub 2016 Jun 28.

PMID:
27219120
22.

Is low molecular weight hyaluronan an early indicator of disease in avian systemic sclerosis?

Kerje S, Hellman U, Do L, Larsson G, Kämpe O, Engström-Laurent A, Lindqvist U.

Connect Tissue Res. 2016 Sep;57(5):337-46. doi: 10.1080/03008207.2016.1182997. Epub 2016 May 2.

PMID:
27135250
23.

Elevated Levels of SOX10 in Serum from Vitiligo and Melanoma Patients, Analyzed by Proximity Ligation Assay.

Blokzijl A, Chen LE, Gustafsdottir SM, Vuu J, Ullenhag G, Kämpe O, Landegren U, Kamali-Moghaddam M, Hedstrand H.

PLoS One. 2016 Apr 25;11(4):e0154214. doi: 10.1371/journal.pone.0154214. eCollection 2016.

24.

MANAGEMENT OF ENDOCRINE DISEASE: Epidemiology, quality of life and complications of primary adrenal insufficiency: a review.

Bensing S, Hulting AL, Husebye ES, Kämpe O, Løvås K.

Eur J Endocrinol. 2016 Sep;175(3):R107-16. doi: 10.1530/EJE-15-1242. Epub 2016 Apr 11. Review.

PMID:
27068688
25.

Autoantibodies Targeting a Collecting Duct-Specific Water Channel in Tubulointerstitial Nephritis.

Landegren N, Pourmousa Lindberg M, Skov J, Hallgren Å, Eriksson D, Lisberg Toft-Bertelsen T, MacAulay N, Hagforsen E, Räisänen-Sokolowski A, Saha H, Nilsson T, Nordmark G, Ohlsson S, Gustafsson J, Husebye ES, Larsson E, Anderson MS, Perheentupa J, Rorsman F, Fenton RA, Kämpe O.

J Am Soc Nephrol. 2016 Oct;27(10):3220-3228. Epub 2016 Mar 16.

26.

Aryl Hydrocarbon Receptor-Interacting Protein-Like 1 in Cancer-Associated Retinopathy.

Dalin F, Adamus G, Yang S, Landgren E, Palle J, Hallgren Å, Frost BM, Hugosson T, Landegren N, Eriksson D, Andréasson S, Tabbara KF, Kämpe O, Alimohammadi M.

Ophthalmology. 2016 Jun;123(6):1401-4. doi: 10.1016/j.ophtha.2015.12.031. Epub 2016 Feb 4. No abstract available.

PMID:
26854037
27.

Proteome-wide survey of the autoimmune target repertoire in autoimmune polyendocrine syndrome type 1.

Landegren N, Sharon D, Freyhult E, Hallgren Å, Eriksson D, Edqvist PH, Bensing S, Wahlberg J, Nelson LM, Gustafsson J, Husebye ES, Anderson MS, Snyder M, Kämpe O.

Sci Rep. 2016 Feb 1;6:20104. doi: 10.1038/srep20104.

28.

Development of autoantibodies against muscle-specific FHL1 in severe inflammatory myopathies.

Albrecht I, Wick C, Hallgren Å, Tjärnlund A, Nagaraju K, Andrade F, Thompson K, Coley W, Phadke A, Diaz-Gallo LM, Bottai M, Nennesmo I, Chemin K, Herrath J, Johansson K, Wikberg A, Ytterberg AJ, Zubarev RA, Danielsson O, Krystufkova O, Vencovsky J, Landegren N, Wahren-Herlenius M, Padyukov L, Kämpe O, Lundberg IE.

J Clin Invest. 2015 Dec;125(12):4612-24. doi: 10.1172/JCI81031. Epub 2015 Nov 9.

29.

Early Exposure to Dogs and Farm Animals and the Risk of Childhood Asthma.

Fall T, Lundholm C, Örtqvist AK, Fall K, Fang F, Hedhammar Å, Kämpe O, Ingelsson E, Almqvist C.

JAMA Pediatr. 2015 Nov;169(11):e153219. doi: 10.1001/jamapediatrics.2015.3219. Epub 2015 Nov 2.

PMID:
26523822
30.

Mammalian CSAD and GADL1 have distinct biochemical properties and patterns of brain expression.

Winge I, Teigen K, Fossbakk A, Mahootchi E, Kleppe R, Sköldberg F, Kämpe O, Haavik J.

Neurochem Int. 2015 Nov;90:173-84. doi: 10.1016/j.neuint.2015.08.013. Epub 2015 Sep 1.

31.

A Multi-Breed Genome-Wide Association Analysis for Canine Hypothyroidism Identifies a Shared Major Risk Locus on CFA12.

Bianchi M, Dahlgren S, Massey J, Dietschi E, Kierczak M, Lund-Ziener M, Sundberg K, Thoresen SI, Kämpe O, Andersson G, Ollier WE, Hedhammar Å, Leeb T, Lindblad-Toh K, Kennedy LJ, Lingaas F, Rosengren Pielberg G.

PLoS One. 2015 Aug 11;10(8):e0134720. doi: 10.1371/journal.pone.0134720. eCollection 2015.

32.

CTLA-4 as a genetic determinant in autoimmune Addison's disease.

Wolff AS, Mitchell AL, Cordell HJ, Short A, Skinningsrud B, Ollier W, Badenhoop K, Meyer G, Falorni A, Kampe O, Undlien D, Pearce SH, Husebye ES.

Genes Immun. 2015 Sep;16(6):430-6. doi: 10.1038/gene.2015.27. Epub 2015 Jul 23.

33.

Transglutaminase 4 as a prostate autoantigen in male subfertility.

Landegren N, Sharon D, Shum AK, Khan IS, Fasano KJ, Hallgren Å, Kampf C, Freyhult E, Ardesjö-Lundgren B, Alimohammadi M, Rathsman S, Ludvigsson JF, Lundh D, Motrich R, Rivero V, Fong L, Giwercman A, Gustafsson J, Perheentupa J, Husebye ES, Anderson MS, Snyder M, Kämpe O.

Sci Transl Med. 2015 Jun 17;7(292):292ra101. doi: 10.1126/scitranslmed.aaa9186.

PMID:
26084804
34.

Determination of 21-hydroxylase autoantibodies: inter-laboratory concordance in the Euradrenal International Serum Exchange Program.

Falorni A, Bini V, Betterle C, Brozzetti A, Castaño L, Fichna M, Kämpe O, Mellgren G, Peterson P, Chen S, Rönnelid J, Seissler J, Tiberti C, Uibo R, Yu L, Lernmark Å, Husebye E.

Clin Chem Lab Med. 2015 Oct;53(11):1761-70. doi: 10.1515/cclm-2014-1106.

PMID:
25811668
35.

Autoantibody response against NALP5/MATER in primary ovarian insufficiency and in autoimmune Addison's disease.

Brozzetti A, Alimohammadi M, Morelli S, Minarelli V, Hallgren Å, Giordano R, De Bellis A, Perniola R, Kämpe O, Falorni A; Italian Addison Network.

J Clin Endocrinol Metab. 2015 May;100(5):1941-8. doi: 10.1210/jc.2014-3571. Epub 2015 Mar 3.

36.

A European Emergency Card for adrenal insufficiency can save lives.

Quinkler M, Dahlqvist P, Husebye ES, Kämpe O.

Eur J Intern Med. 2015 Jan;26(1):75-6. doi: 10.1016/j.ejim.2014.11.006. Epub 2014 Dec 11. No abstract available.

PMID:
25498511
37.

Circadian hormone profiles and insulin sensitivity in patients with Addison's disease: a comparison of continuous subcutaneous hydrocortisone infusion with conventional glucocorticoid replacement therapy.

Björnsdottir S, Øksnes M, Isaksson M, Methlie P, Nilsen RM, Hustad S, Kämpe O, Hulting AL, Husebye ES, Løvås K, Nyström T, Bensing S.

Clin Endocrinol (Oxf). 2015 Jul;83(1):28-35. doi: 10.1111/cen.12670. Epub 2015 Jan 12.

PMID:
25400085
38.

Clinical and serologic parallels to APS-I in patients with thymomas and autoantigen transcripts in their tumors.

Wolff AS, Kärner J, Owe JF, Oftedal BE, Gilhus NE, Erichsen MM, Kämpe O, Meager A, Peterson P, Kisand K, Willcox N, Husebye ES.

J Immunol. 2014 Oct 15;193(8):3880-90. doi: 10.4049/jimmunol.1401068. Epub 2014 Sep 17.

39.

Lack of evidence for a role of islet autoimmunity in the aetiology of canine diabetes mellitus.

Ahlgren KM, Fall T, Landegren N, Grimelius L, von Euler H, Sundberg K, Lindblad-Toh K, Lobell A, Hedhammar Å, Andersson G, Hansson-Hamlin H, Lernmark Å, Kämpe O.

PLoS One. 2014 Aug 25;9(8):e105473. doi: 10.1371/journal.pone.0105473. eCollection 2014.

40.

High frequency of cytolytic 21-hydroxylase-specific CD8+ T cells in autoimmune Addison's disease patients.

Dawoodji A, Chen JL, Shepherd D, Dalin F, Tarlton A, Alimohammadi M, Penna-Martinez M, Meyer G, Mitchell AL, Gan EH, Bratland E, Bensing S, Husebye ES, Pearce SH, Badenhoop K, Kämpe O, Cerundolo V.

J Immunol. 2014 Sep 1;193(5):2118-26. doi: 10.4049/jimmunol.1400056. Epub 2014 Jul 25.

41.

Altered expression of autoimmune regulator in infant down syndrome thymus, a possible contributor to an autoimmune phenotype.

Skogberg G, Lundberg V, Lindgren S, Gudmundsdottir J, Sandström K, Kämpe O, Annerén G, Gustafsson J, Sunnegårdh J, van der Post S, Telemo E, Berglund M, Ekwall O.

J Immunol. 2014 Sep 1;193(5):2187-95. doi: 10.4049/jimmunol.1400742. Epub 2014 Jul 18.

42.

The role of pleiotropy and linkage in genes affecting a sexual ornament and bone allocation in the chicken.

Johnsson M, Rubin CJ, Höglund A, Sahlqvist AS, Jonsson KB, Kerje S, Ekwall O, Kämpe O, Andersson L, Jensen P, Wright D.

Mol Ecol. 2014 May;23(9):2275-86. doi: 10.1111/mec.12723. Epub 2014 Apr 9.

PMID:
24655072
43.

Association of autoimmune Addison's disease with alleles of STAT4 and GATA3 in European cohorts.

Mitchell AL, Macarthur KD, Gan EH, Baggott LE, Wolff AS, Skinningsrud B, Platt H, Short A, Lobell A, Kämpe O, Bensing S, Betterle C, Kasperlik-Zaluska A, Zurawek M, Fichna M, Kockum I, Nordling Eriksson G, Ekwall O, Wahlberg J, Dahlqvist P, Hulting AL, Penna-Martinez M, Meyer G, Kahles H, Badenhoop K, Hahner S, Quinkler M, Falorni A, Phipps-Green A, Merriman TR, Ollier W, Cordell HJ, Undlien D, Czarnocka B, Husebye E, Pearce SH.

PLoS One. 2014 Mar 10;9(3):e88991. doi: 10.1371/journal.pone.0088991. eCollection 2014. Erratum in: PLoS One. 2014;9(7):e102428.

44.

Continuous subcutaneous hydrocortisone infusion versus oral hydrocortisone replacement for treatment of addison's disease: a randomized clinical trial.

Oksnes M, Björnsdottir S, Isaksson M, Methlie P, Carlsen S, Nilsen RM, Broman JE, Triebner K, Kämpe O, Hulting AL, Bensing S, Husebye ES, Løvås K.

J Clin Endocrinol Metab. 2014 May;99(5):1665-74. doi: 10.1210/jc.2013-4253. Epub 2014 Feb 11.

PMID:
24517155
45.

Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency.

Husebye ES, Allolio B, Arlt W, Badenhoop K, Bensing S, Betterle C, Falorni A, Gan EH, Hulting AL, Kasperlik-Zaluska A, Kämpe O, Løvås K, Meyer G, Pearce SH.

J Intern Med. 2014 Feb;275(2):104-15. doi: 10.1111/joim.12162. Epub 2013 Dec 16. Review.

46.

BPIFB1 is a lung-specific autoantigen associated with interstitial lung disease.

Shum AK, Alimohammadi M, Tan CL, Cheng MH, Metzger TC, Law CS, Lwin W, Perheentupa J, Bour-Jordan H, Carel JC, Husebye ES, De Luca F, Janson C, Sargur R, Dubois N, Kajosaari M, Wolters PJ, Chapman HA, Kämpe O, Anderson MS.

Sci Transl Med. 2013 Oct 9;5(206):206ra139. doi: 10.1126/scitranslmed.3006998.

47.

Drug prescription patterns in patients with Addison's disease: a Swedish population-based cohort study.

Björnsdottir S, Sundström A, Ludvigsson JF, Blomqvist P, Kämpe O, Bensing S.

J Clin Endocrinol Metab. 2013 May;98(5):2009-18. doi: 10.1210/jc.2012-3561. Epub 2013 Mar 29.

PMID:
23543658
48.

Intermediate lobe immunoreactivity in a patient with suspected lymphocytic hypophysitis.

Smith CJ, Bensing S, Maltby VE, Zhang M, Scott RJ, Smith R, Kämpe O, Hökfelt T, Crock PA.

Pituitary. 2014 Feb;17(1):22-9. doi: 10.1007/s11102-013-0461-9.

PMID:
23329361
49.

Risk of thyroid cancer in a nationwide cohort of patients with biopsy-verified celiac disease.

Ludvigsson JF, Lebwohl B, Kämpe O, Murray JA, Green PH, Ekbom A.

Thyroid. 2013 Aug;23(8):971-6. doi: 10.1089/thy.2012.0306. Epub 2013 Jul 22.

50.

Autoantibodies against aromatic amino acid hydroxylases in patients with autoimmune polyendocrine syndrome type 1 target multiple antigenic determinants and reveal regulatory regions crucial for enzymatic activity.

Bratland E, Magitta NF, Bøe Wolff AS, Ekern T, Knappskog PM, Kämpe O, Haavik J, Husebye ES.

Immunobiology. 2013 Jun;218(6):899-909. doi: 10.1016/j.imbio.2012.10.006. Epub 2012 Oct 26.

PMID:
23182718

Supplemental Content

Support Center